Orphazyme A/S (CPH: ORPHA)

Orphazyme Ratios and Metrics

Market cap in millions DKK. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Oct 1, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	50	47	31	600	2,328	1,447
Market Cap Growth	19.83%	51.14%	-94.82%	-74.24%	60.91%	67.39%
Enterprise Value	32	17	-18	324	1,799	1,231
Last Close Price	1190.00	1330.00	880.00	17160.00	67100.00	72400.00
PE Ratio	-	-1.80	0.88	-0.96	-3.01	-4.30
PB Ratio	2.61	3.30	0.76	64.22	3.75	27.31
P/FCF Ratio	-4.17	-2.35	-0.26	-1.00	-4.30	-4.39
P/OCF Ratio	-4.17	-2.35	-0.26	-1.00	-4.32	-4.43
EV/EBITDA Ratio	-	-1.37	0.46	-4.61	-2.97	-3.68
EV/EBIT Ratio	17.29	-1.29	0.45	-3.88	-2.96	-3.66
EV/FCF Ratio	-1.95	-0.83	0.16	-0.54	-3.32	-3.73
Debt / Equity Ratio	-	-	-	4.28	0.11	1.46
Debt / FCF Ratio	-	-	-	-0.07	-0.13	-0.23
Quick Ratio	10.08	3.81	3.50	1.13	4.47	2.04
Current Ratio	10.14	3.81	3.61	1.23	4.70	2.25
Return on Equity (ROE)	-50.77%	-94.35%	-152.27%	-24.92%	-188.05%	-152.98%
Return on Assets (ROA)	4.27%	-21.15%	-22.41%	-10.48%	-75.82%	-67.50%
Return on Capital (ROIC)	5.13%	-29.17%	-57.10%	-14.09%	-92.62%	-81.02%
Earnings Yield	-27.16%	-55.46%	112.86%	-104.46%	-27.20%	-23.33%
FCF Yield	-23.96%	-42.63%	-379.55%	-100.48%	-23.26%	-22.78%
Buyback Yield / Dilution	0.02%	-0.12%	-0.98%	-23.12%	-41.65%	-0.08%
Total Shareholder Return	0.02%	-0.12%	-0.98%	-23.12%	-41.65%	-0.08%

Source: S&P Capital IQ. Standard template. Financial Sources.